GlassScriptPhysician profile
Briteny L Johnson
NPI 1700458411
$1,149.47
in general payments reported to CMS, 2019-2025
17 companies · $142 in 2025
The $142 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $133 · 2022: $292 · 2023: $402 · 2024: $180 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $724.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $724.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $363.48 | 2021-2025 | Jardiance |
| Pfizer INC. | $166.24 | 2021-2024 | |
| Cvrx, INC. | $149.90 | 2022-2023 | Barostim Neo System |
| Daiichi Sankyo INC. | $87.70 | 2021-2024 | Injectafer |
| Abbvie INC. | $83.64 | 2021-2024 | |
| Boston Scientific Corporation | $73.18 | 2022-2025 | Watchman Flx, Enroute Transcarotid Neuroprotection System, Watchman Access System |
| Atricure, INC. | $64.93 | 2024-2025 | Atriclip Laa Exclusion System |
| Kiniksa Pharmaceuticals, LTD. | $29.04 | 2022-2023 | Arcalyst |
| Inspire Medical Systems, INC. | $21.91 | 2025 | Inspire |
| Astrazeneca Pharmaceuticals LP | $17.23 | 2023 | Andexxa |
| United Therapeutics Corporation | $17.05 | 2025 | Tyvaso |
| E.R. Squibb & Sons, L.L.C. | $14.65 | 2024 | Camzyos |
| Actelion Pharmaceuticals US, INC. | $13.65 | 2023 | Uptravi, Opsumit |
| La Jolla Pharmaceutical Company | $12.97 | 2023 | Giapreza |
| Amgen INC. | $12.10 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $11.05 | 2023 | Lifevest |
| Lemaitre Vascular, INC. | $10.75 | 2023 | Artegraft Vascular Graft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Briteny Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.